| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K Tsuruda, Y Yamada, Y Hirakata, K Sugahara, T Maeda, S Atogami, M Tomonaga, S Kamihir. Qualitative and quantitative characterization of Fas (APO-1/CD95) on leukemic cells derived from patients with B-cell neoplasms. Leukemia research. vol 23. issue 2. 1999-03-16. PMID:10071131. |
short-term culture of freshly isolated cells gave rise to increases of fas density and susceptibility for apoptosis, suggesting that the mrna and inducible fas are functional at least in vitro. |
1999-03-16 |
2023-08-12 |
Not clear |
| J L Kissil, O Cohen, T Raveh, A Kimch. Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell death. The EMBO journal. vol 18. issue 2. 1999-03-15. PMID:9889192. |
expression of anti-sense dap3 rna and of the dominant interfering form of dap3 both protected cells from apoptosis induced by activation of fas and tumor necrosis factor alpha (tnf-alpha) receptors. |
1999-03-15 |
2023-08-12 |
human |
| S C Chow, E A Slee, M MacFarlane, G M Cohe. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells. Experimental cell research. vol 246. issue 2. 1999-03-15. PMID:9925765. |
time-course studies showed no caspase-1 activity during the activation of apoptosis in jurkat cells by agonistic fas antibodies. |
1999-03-15 |
2023-08-12 |
Not clear |
| S C Chow, E A Slee, M MacFarlane, G M Cohe. Caspase-1 is not involved in CD95/Fas-induced apoptosis in Jurkat T cells. Experimental cell research. vol 246. issue 2. 1999-03-15. PMID:9925765. |
taken together our results demonstrate that caspase-1 is not required for the induction of apoptosis in jurkat t cells mediated by the fas antigen. |
1999-03-15 |
2023-08-12 |
Not clear |
| F Silvestris, P Cafforio, G Camarda, M Tucci, M A Frassanito, F Dammacc. Functional Fas-ligand expression on T cells from HIV-1-infected patients is unrelated to CD4+ lymphopenia. International journal of clinical & laboratory research. vol 28. issue 4. 1999-03-12. PMID:9879494. |
recent studies have demonstrated that the expression of fas by peripheral t cells from hiv-1+ patients is deregulated and increases the susceptibility of these cells to undergo apoptosis. |
1999-03-12 |
2023-08-12 |
mouse |
| T Sawa, F Nishimura, H Ohyama, K Takahashi, S Takashiba, Y Murayam. In vitro induction of activation-induced cell death in lymphocytes from chronic periodontal lesions by exogenous Fas ligand. Infection and immunity. vol 67. issue 3. 1999-03-12. PMID:10024594. |
these results indicate that lymphocytes in the lesions are susceptible to activation-induced cell death and are induced to die by apoptosis after the addition of exogenous fas ligand. |
1999-03-12 |
2023-08-12 |
Not clear |
| C T Dang, M S Magid, B Weksler, A Chadburn, J Laurenc. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura. Blood. vol 93. issue 4. 1999-03-11. PMID:9949169. |
we have previously demonstrated that plasmas from patients with both idiopathic ttp and a related disorder, sporadic hemolytic-uremic syndrome (hus), induce apoptosis and expression of the apoptosis-associated molecule fas (cd95) in vitro in those lineages of microvascular endothelial cells (mvecs) that are affected pathologically. |
1999-03-11 |
2023-08-12 |
Not clear |
| L L Loro, O K Vintermyr, A C Johannessen, P G Liavaag, R Jonsso. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. vol 28. issue 2. 1999-03-11. PMID:9950255. |
suppression of fas receptor and negative correlation of fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. |
1999-03-11 |
2023-08-12 |
Not clear |
| L L Loro, O K Vintermyr, A C Johannessen, P G Liavaag, R Jonsso. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. vol 28. issue 2. 1999-03-11. PMID:9950255. |
apoptosis and the expression of fas receptor (fas) and fas ligand (fasl) were studied in 8 samples of normal oral mucosa (om) and in 19 oral squamous cell carcinomas (oscc) by immunohistochemistry and the tunel method. |
1999-03-11 |
2023-08-12 |
Not clear |
| L L Loro, O K Vintermyr, A C Johannessen, P G Liavaag, R Jonsso. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. vol 28. issue 2. 1999-03-11. PMID:9950255. |
our results show that fas is expressed in low quantities in oscc and that fasl expression correlates negatively with degree of differentiation and apoptosis in oscc. |
1999-03-11 |
2023-08-12 |
Not clear |
| M S Hu, J D Schwartzman, G R Yeaman, J Collins, R Seguin, I A Khan, L H Kaspe. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infection and immunity. vol 67. issue 2. 1999-03-09. PMID:9916110. |
intraocular inflammation, fas and fasl expression on lymphocytes and on ocular tissues, the occurrence of apoptosis, and the frequency of cd8(+) and cd4(+) t cells in the infected eyes were analyzed in c57bl/6 (b6) mice. |
1999-03-09 |
2023-08-12 |
mouse |
| M Drozdzik, C Qian, J J Lasarte, R Bilbao, J Priet. Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL). Gene therapy. vol 5. issue 12. 1999-03-09. PMID:10023441. |
fas ligand is a type ii transmembrane protein which can induce apoptosis in fas-expressing cells. |
1999-03-09 |
2023-08-12 |
Not clear |
| M K Squier, A J Sehnert, K S Sellins, A M Malkinson, E Takano, J J Cohe. Calpain and calpastatin regulate neutrophil apoptosis. Journal of cellular physiology. vol 178. issue 3. 1999-03-04. PMID:9989777. |
nevertheless, apoptosis signalled via the fas antigen proceeds regardless of the presence of calpain inhibitor. |
1999-03-04 |
2023-08-12 |
mouse |
| H W Findley, M Zho. The clinical significance of Fas expression in leukemia: questions and controversies. Leukemia. vol 13. issue 2. 1999-03-04. PMID:10025885. |
binding of agonistic anti-fas (apo-1/cd95) antibodies or fas ligand (fas-l) induces apoptosis in some fas+ leukemias, and anti-fas antibody was originally investigated as a possible therapeutic reagent. |
1999-03-04 |
2023-08-12 |
Not clear |
| W Yu, K Israel, Q Y Liao, C M Aldaz, B G Sanders, K Klin. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer research. vol 59. issue 4. 1999-03-04. PMID:10029090. |
vitamin e succinate (ves) induces fas sensitivity in human breast cancer cells: role for mr 43,000 fas in ves-triggered apoptosis. |
1999-03-04 |
2023-08-12 |
human |
| W Yu, K Israel, Q Y Liao, C M Aldaz, B G Sanders, K Klin. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer research. vol 59. issue 4. 1999-03-04. PMID:10029090. |
fas (cd95/apo-1) is an important mediator of apoptosis. |
1999-03-04 |
2023-08-12 |
human |
| W Yu, K Israel, Q Y Liao, C M Aldaz, B G Sanders, K Klin. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer research. vol 59. issue 4. 1999-03-04. PMID:10029090. |
although ves is itself a potent apoptotic triggering agent, the 6-h pretreatment procedure for fas sensitization did not initiate ves-mediated apoptosis. |
1999-03-04 |
2023-08-12 |
human |
| W Yu, K Israel, Q Y Liao, C M Aldaz, B G Sanders, K Klin. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer research. vol 59. issue 4. 1999-03-04. PMID:10029090. |
functional knockout of fas-mediated signaling with either fas-neutralizing antibody (mcf-7-, mda-mb-231-, and mda-mb-435-treated cells) or fas antisense oligomers (mda-mb-435-treated cells only), reduced ves-triggered apoptosis by approximately 50%. |
1999-03-04 |
2023-08-12 |
human |
| W Yu, K Israel, Q Y Liao, C M Aldaz, B G Sanders, K Klin. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis. Cancer research. vol 59. issue 4. 1999-03-04. PMID:10029090. |
these data show that ves can convert fas-resistant human breast cancer cells to a fas-sensitive phenotype, perhaps by translocation of cytosolic mr 43,000 fas to the membrane and show that ves-mediated apoptosis involves mr 43,000 fas signaling. |
1999-03-04 |
2023-08-12 |
human |
| J A Houghton, F G Harwood, A A Gibson, D M Tillma. The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis. Clinical cancer research : an official journal of the American Association for Cancer Research. vol 3. issue 12 Pt 1. 1999-03-03. PMID:9815616. |
the fas signaling pathway is functional in colon carcinoma cells and induces apoptosis. |
1999-03-03 |
2023-08-12 |
Not clear |